Navigation Links
HIV Drugs Unaffordable for Common Man: Kalam

Urging the medical community to develop 'much cheaper' drugs to combat HIV/AIDS, President A P J Abdul Kalam today said the available first and second line treatment of the deadly disease is still out of reach of the common man in the country.

Stating that the Indian companies have done formidable job in bringing down the price of first and second line HIV drugs, Kalam said: "Even this reduction does not make the drug affordable to the common man in our country."

Speaking at Mahatma Gandhi Institute of Medical Sciences (MGIMS) at Sevagram, he said: "We have Technology Vision 2020 Document prepared by TIFAC (Technology Information, Forecasting and Assessment Council), which indicates about the typical disease pattern which will be faced by the country during the period now to the year 2020."

"It is expected that HIV and TB combination, water borne diseases, cardiac diseases will be the predominant diseases and we have to find solutions for diagnosing and treatment," he added.

Kalam emphasised the need for providing quality health care to our rural citizens.

Commenting on the infant mortality rate, Kalam called for bringing infant mortality to less than 10 per thousand.

On the menace on malaria, he said: "Italian scientists have recently found a bacteria that lived symbiotically inside the pest. They claim that such bacteria could potentially be genetically altered later to attack the Malaria parasite when it reaches the Mosquitoes."


'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/29/2017)... ... May 29, 2017 , ... A New York high ... 6 month test of the effectiveness of Artificial Intelligence (AI) in helping nudge men ... health game,’ said Wayne Hartrick, President of the Canadian Men’s Health Foundation (CMHF), whose ...
(Date:5/28/2017)... Winter Haven, FL (PRWEB) , ... May 28, ... ... Physician Partners of America (PPOA), is proud to announce that Sheldon K. Cho, ... on comprehensive interventional pain management, a specialty that concentrates on minimally invasive techniques ...
(Date:5/27/2017)... ... ... From May 21-23, hearing healthcare professionals gained a competitive edge with training ... Syracuse Downtown Hotel in Syracuse, New York. , As EarQ’s technology partner, Oticon ... to help them stay ahead in the industry. At the event, EarQ members learned ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... a new educational seminar to focus on current legislative activity and the latest ... begin at 1 p.m. Sunday, Sept. 10, and will continue through Monday, Sept. ...
(Date:5/26/2017)... Nevada (PRWEB) , ... May 26, 2017 , ... ... produce the first ever copper, antimicrobial, mesh back 24/7 task chair specifically designed ... conference applications. “We are thrilled to partner with Cupron® to provide customers ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... -- Enterin Inc., a privately-held CNS pharmaceutical company based in ... treat Parkinson,s disease (PD), has enrolled the first patient in ... controlled, multicenter study involving patients with PD and taking place ... a 9-to-12-month period. The first stage is open label and ... sites include Denver , Boca ...
(Date:5/10/2017)... 10, 2017  The Corporate Whistleblower Center says, ... sleep therapy clinics to call us anytime at ... is involved in a substantial scheme to overbill ... from an employee of a medical equipment company ... to provide medical practice groups with extra generous incentives ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
Breaking Medicine Technology: